Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 165.45M P/E - EPS this Y 20.70% Ern Qtrly Grth -
Income -298.45M Forward P/E -1.44 EPS next Y 49.90% 50D Avg Chg -53.00%
Sales - PEG -0.04 EPS past 5Y - 200D Avg Chg -52.00%
Dividend N/A Price/Book 0.42 EPS next 5Y 12.40% 52W High Chg -75.00%
Recommedations 3.60 Quick Ratio 5.10 Shares Outstanding 52.45M 52W Low Chg 14.00%
Insider Own 5.71% ROA -28.53% Shares Float 31.96M Beta 1.72
Inst Own 79.77% ROE -68.66% Shares Shorted/Prior 2.71M/2.18M Price 3.16
Gross Margin - Profit Margin - Avg. Volume 1,184,417 Target Price 4.00
Oper. Margin - Earnings Date Nov 7 Volume 1,009,541 Change 5.33%
About Kodiak Sciences Inc

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Kodiak Sciences Inc News
09/13/23 Kodiak Sciences Inc. (KOD) Down 19.9% Since Last Earnings Report: Can It Rebound?
09/08/23 Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
09/07/23 New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion
09/05/23 Owning 49% shares,institutional owners seem interested in Kodiak Sciences Inc. (NASDAQ:KOD),
08/16/23 Kodiak (KOD) Q2 Earnings Miss, New Lead Candidate in Focus
08/14/23 While dollars continue to flow into biotech, companies cut more jobs
08/14/23 Kodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights
08/14/23 Should You Buy Kodiak Sciences (KOD) Ahead of Earnings?
08/14/23 3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
08/02/23 Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?
07/27/23 4 big analyst cuts: Carvana 'well above our increased target,' says Morgan Stanley
07/26/23 Kodiak Sciences Inc. (NASDAQ:KOD) Is Expected To Breakeven In The Near Future
08:16 AM Kodiak (KOD) Down as Late-Stage DME Studies Fail
07/24/23 CORRECTED-UPDATE 1-Kodiak Sciences scraps development of eye disorder drug
07/24/23 Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development Program
06/14/23 Why Is Kodiak Sciences Inc. (KOD) Up 62.9% Since Last Earnings Report?
05/30/23 Kodiak Sciences to Present at Upcoming Investor Conferences
05/30/23 Kodiak (KOD) Advances With Tarcocimab Amid Stiff Competition
05/16/23 Kodiak's (KOD) Q1 Earnings Miss, Pipeline in Focus, Stock Up
05/15/23 Kodiak Sciences Announces First Quarter 2023 Financial Results and Recent Business Highlights
KOD Chatroom

User Image dividendinvestorbyeagle Posted - 1 day ago

$KOD hit 52 week low (Kodiak Sciences Inc) https://www.dividendinvestor.com/dividend-news/?symbol=kod http://dlvr.it/SwWpnY

User Image apple915 Posted - 2 days ago

$KOD, Victor, and his Co. Must go to jail.

User Image damenroy Posted - 3 days ago

$AVTX closing in on 229 million in volume 💰 $GME $KOD

User Image biomaster22 Posted - 3 days ago

$KOD $ 1.99 how are these fools still employed, well at least they lost there their stock options value

User Image towll76 Posted - 4 days ago

$KOD I’m a shareholder and i joined a class action lawsuit against KOD. You can too!

User Image Im_not_Mr_Lebowski Posted - 4 days ago

$KOD No. They can't sell. They need buyers. Who would buy this? They are stuck with a massive, worthless position.

User Image biotechie53 Posted - 4 days ago

$KOD Victor and the thieves creating shareholder value while protecting their jobs! You can see it in the stock price. These pigs should have paid a special cash dividend and close down the company. The board of directors should be kicked out immediately. Baker Bros are at sleep. I thought they are running this company with the 33% shareholding.

User Image apple915 Posted - 4 days ago

$KOD , Victor you sick f111k.

User Image apple915 Posted - 4 days ago

$KOD , Once BB start dumping this will be in penny land.

User Image apple915 Posted - 4 days ago

$KOD , Institutions getting out. This will get really ugly. Watch out for $ 1.50. Glad sold @ $ 4.00.

User Image tahloolaaa Posted - 4 days ago

$KOD i cant tell, is the trend still down?

User Image biomaster22 Posted - 6 days ago

$KOD I wan to hear from the BB ?

User Image Kelly12 Posted - 6 days ago

$KOD why are Bakers still holding? Haven’t sold or bought more on the dip

User Image apple915 Posted - 1 week ago

$KOD , $ 1.50 soon.

User Image apple915 Posted - 1 week ago

$KOD ,Victor is a pathological liar.

User Image Paultown1 Posted - 1 week ago

$KOD Yep, CEO is on live right now…and it’s confirmed, they’re still chasing this drug…so not good for this stock. He says it will be another quarter of from their last trial before they make any decision. Throw in the towel and this stock doubles overnight…the biotech IPO market is starving for capital…they could use this cash to get a very favorable valuation in a reverse merger with a new drug in Phase 2/3. Its so simple what their shareholders want.

User Image Calcs Posted - 1 week ago

$KOD unfucking believable …. He went to Morgan Stanley to establish the validity of his shit platform so he can start 501 ….. amazing. The amazing American greed saga….

User Image apple915 Posted - 1 week ago

$KOD, going below $ 2 soon and $ 1.50 by year end. Same old crap...Victor = loser.

User Image adayxs Posted - 1 week ago

$KOD They are going to try and build excitement around the new path in the next quarter. In doing that they hope to bring the share price up to at least cash value. I like what I heard.

User Image adayxs Posted - 1 week ago

$KOD So 301 is not dead, just put on hold. Interesting.

User Image sistermojo Posted - 1 week ago

$KOD this is one of them I'm so glad I got out of usually I hang on to my losers way too long

User Image biotechie53 Posted - 1 week ago

$KOD I am out. Took a hit 200k. I thought the cash balance will protect me. These Aholes will never do the right think but protect their jobs.

User Image apple915 Posted - 1 week ago

$KOD 😁😇

User Image biotechie53 Posted - 1 week ago

$KOD I totally agree. This is why I am mad as hell they are going to NY. There is no purpose other than them getting a free trip. They will finish the cash in 6-12 months if they function at current speed. That gives them time to find jobs. I thought Baker Bros are smarter than this!

User Image Paultown1 Posted - 1 week ago

$KOD Doesn’t bode well that they’re presenting at a conference tomorrow…means they’re not letting go of this drug. This pops when they announce they’re pursuing strategic alternatives—but they won’t do that tomorrow…you don’t go to a conference to talk about that. Tomorrow will unfortunately be more validation they want to draw paychecks for the next 3 years and chase this futile drug. That will probably lead to more selling and this going under $2. But they’ll get the memo eventually…or an activist will start buying up shares in the $1s and get them out.

User Image _www_larval_com_ Posted - 1 week ago

$KOD just slipped -6% lower to -2% (~298Kv) a moment ago, 09/15 options, follow for more volatility.

User Image apple915 Posted - 1 week ago

$KOD , 20 cent up. 40 cent down. Victor you d11mp fkk.

User Image FE123 Posted - 1 week ago

$KOD Vicktor needs to ho to Jail!!

User Image Cutlass Posted - 2 weeks ago

$KOD 2.11 working

User Image biotechie53 Posted - 2 weeks ago

$KOD ENLV probably has other viable products. KOD is trying to scam people to believe they have 501 which is sure to fail too. This is a game they are playing to keep their jobs. Only viable option for this company is to close down its operations and return the cash to its shareholders, true owners of the company.

Analyst Ratings
UBS Neutral Jul 27, 23
Chardan Capital Neutral Jul 25, 23
Barclays Underweight Jul 25, 23
JP Morgan Underweight Jul 25, 23
Jefferies Hold Jul 24, 23
Capital One Equal-Weight Jul 24, 23
JP Morgan Neutral Apr 4, 23
Morgan Stanley Equal-Weight Nov 14, 22
Goldman Sachs Neutral Nov 10, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
EHRLICH JASON See Remarks See Remarks Jun 14 Sell 9.33 3,390 31,629 61,924 06/16/23
BORGESON JOHN A. See Remarks See Remarks Jun 14 Sell 9.33 4,197 39,158 178,077 06/16/23
EHRLICH JASON See Remarks See Remarks Jun 15 Sell 7.12 3,487 24,827 56,920 06/17/22
BORGESON JOHN A. See Remarks See Remarks Jun 15 Sell 7.12 4,343 30,922 173,755 06/17/22
BAKER BROS. ADVISORS LP Director Director Jun 02 Buy 7.77 572,349 4,447,152 15,967,504 06/06/22
BAKER BROS. ADVISORS LP Director Director May 16 Buy 5.9 456,690 2,694,471 15,142,074 05/18/22
PERLROTH VICTOR Chairman and CEO Chairman and CEO Feb 24 Sell 9.09 1,340,000 12,180,600 2,168,038 02/28/22
BAKER BROS. ADVISORS LP Director Director Feb 15 Buy 54.11 400,965 21,696,216 14,734,965 02/17/22
BAKER BROS. ADVISORS LP Director Director Jan 27 Buy 52.1 347,665 18,113,346 14,364,512 01/31/22
BAKER BROS. ADVISORS LP Director Director Jan 21 Buy 57.62 501,111 28,874,016 14,027,837 01/25/22
EHRLICH JASON See Remarks See Remarks Jan 20 Option 10.29 6,950 71,516 58,491 01/24/22
EHRLICH JASON See Remarks See Remarks Jan 20 Sell 64.9 6,950 451,055 51,541 01/24/22
EHRLICH JASON See Remarks See Remarks Oct 20 Option 10.29 6,950 71,516 58,491 10/22/21
EHRLICH JASON See Remarks See Remarks Oct 20 Sell 112.15 6,950 779,442 51,541 10/22/21
BAKER BROS. ADVISORS LP Director Director Sep 09 Buy 93.12 57,501 5,354,493 13,269,155 09/09/21